WALTHAM, Mass., March 04, 2025 (GLOBE NEWSWIRE) -- FluidForm Bio™, a leader in cell therapies for chronic diseases such as type 1 diabetes, today announced that Adam Feinberg, PhD, FluidForm ...

Hackensack Meridian Health and its Bear’s Den innovation program have invested in FluidForm, which recreates human tissue for drug discovery, surgical repair, and organ donation. The investment, ...

WALTHAM, Mass., March 31, 2025 (GLOBE NEWSWIRE) -- FluidForm Bio™, a leader in cell therapies for chronic diseases such as type 1 diabetes, today announced that Mike Graffeo, CEO and co-founder, will ...

(MENAFN- GlobeNewsWire - Nasdaq) WALTHAM, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- FluidForm BioTM, a leader in cell therapies for chronic diseases such as type 1 diabetes, today announced a major ...

FluidForm Bio, a leader in developing life-like human tissue to treat disease, shares recent advancements in building human cardiac tissues using FRESH ™ 3D bioprinting. Recently published in APL ...

FluidForm Bio, a leader in developing life-like human tissue to treat disease, shares recent advancements in building human cardiac tissues using FRESH ™ 3D bioprinting. Recently published in APL ...

LOVELAND, Colo.--(BUSINESS WIRE)--Aleph Objects, Inc., manufacturer of LulzBot 3D Printers, announced their collaboration with FluidForm Inc., an innovator in 3D bioprinting. FluidForm’s FRESH ...

New study establishes CHIPS as a foundation for engineered, vascularized, insulin-producing tissue systems WALTHAM, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- FluidForm Bio™, a leader in cell therapies ...

Organ transplantation is one of the greatest innovations of modern medicine. Unfortunately, there is an immense shortage in the number of organs available for transplantation, leading to long wait ...

In addition to a corporate update, FluidForm will share data on its lead program in islet cell replacement therapy. A critical factor for the success of islet cell replacement therapy is the promotion ...